Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership123,790 shares
Latest Disclosed Value $ 495,160
Alliancebernstein L.p. reports 2.52% decrease in ownership of 9EH / Evolent Health, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 123,790 shares of Evolent Health, Inc. (DE:9EH) valued at $233,963 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 126,990 shares of Evolent Health, Inc.. This represents a change in shares of -2.52% during the quarter. The current value of the position is $418,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 123,790 -3,200 -2.52 495 -2.37 0.0002
2026-02-17 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 126,990 -103 -0.08 508 -52.84 0.0002
2025-11-14 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 127,093 0 0.00 1,075 -24.88 0.0003
2025-08-14 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 127,093 0 0.00 1,431 18.95 0.0005
2025-05-15 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 127,093 -660 -0.52 1,204 -16.28 0.0004
2025-02-12 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 127,753 -100,004 -43.91 1,437 -77.69 0.0005
2024-11-14 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 227,757 64,639 39.63 6,441 106.54 0.0022
2024-08-14 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 163,118 -144,143 -46.91 3,119 -69.05 0.0011
2024-05-14 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 307,261 -40,551 -11.66 10,075 -12.30 0.0036
2024-02-14 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 347,812 15,398 4.63 11,488 26.93 0.0044
2023-11-14 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 332,414 38,084 12.94 9,052 1.49 0.0039
2023-08-15 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 294,330 167,829 132.67 8,918 117.30 0.0036
2023-05-15 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 126,501 -23,169 -15.48 4,105 -2.33 0.0018
2023-02-15 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 149,670 58,870 64.83 4,203 28.82 0.0019
2022-11-15 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 90,800 0 0.00 3,262 17.00 0.0016
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 90,800 0 0.00 2,788 -4.94 0.0013
2022-05-13 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 90,800 200 0.22 2,933 16.99 0.0011
2022-02-14 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 90,600 -11,600 -11.35 2,507 -20.86 0.0009
2021-11-10 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 102,200 -5,500 -5.11 3,168 39.25 0.0012
2021-07-30 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 107,700 14,400 15.43 2,275 20.69 0.0009
2021-05-06 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 93,300 2,100 2.30 1,885 28.93 0.0008
2021-02-08 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 91,200 0 0.00 1,462 29.15 0.0007
2020-11-12 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 91,200 -2,000 -2.15 1,132 70.48 0.0006
2020-08-13 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 93,200 -5,100 -5.19 664 24.34 0.0004
2020-05-14 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 98,300 13,000 15.24 534 -30.83 0.0004
2020-02-18 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 85,300 -38 -0.04 772 25.73 0.0004
2019-11-14 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 85,338 38 0.04 614 -9.44 0.0004
2019-08-14 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 85,300 0 0.00 678 -36.81 0.0004
2019-05-14 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 85,300 0 0.00 1,073 -36.96 0.0007
2019-02-13 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 85,300 -700 -0.81 1,702 -30.30 0.0013
2018-11-08 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 86,000 0 0.00 2,442 34.92 0.0016
2018-08-13 2018-06-30 13F EVOLENT HEALTH CL A 30050B101 86,000 24,277 39.33 1,810 105.68 0.0013
2018-05-14 2018-03-31 13F EVOLENT HEALTH CL A 30050B101 61,723 1,123 1.85 880 18.12 0.0006
2018-02-13 2017-12-31 13F EVOLENT HEALTH CL A 30050B101 60,600 2,100 3.59 745 -28.43 0.0005
2017-11-13 2017-09-30 13F EVOLENT HEALTH CL A 30050B101 58,500 0 0.00 1,041 -29.80 0.0008
2017-08-10 2017-06-30 13F EVOLENT HEALTH CL A 30050B101 58,500 34,700 145.80 1,483 179.28 0.0011
2017-05-11 2017-03-31 13F EVOLENT HEALTH CL A 30050B101 23,800 0 0.00 531 50.85 0.0004
2017-02-13 2016-12-31 13F EVOLENT HEALTH CL A 30050B101 23,800 5,400 29.35 352 -22.30 0.0003
2016-11-10 2016-09-30 13F EVOLENT HEALTH CL A 30050B101 18,400 3,900 26.90 453 62.95 0.0004
2016-08-11 2016-06-30 13F EVOLENT HEALTH CL A 30050B101 14,500 14,500 278 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.